Senzime Investor Relations Material
Latest events
Q4 2023
Senzime
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Senzime
Access all reports
Senzime AB develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. It offers the Azone® line for continuous monitoring of pulse oximetry; the Anesthesia Management Module for control displays that show multiple parameters used during anesthesia; and the S-Series® line that provides noninvasive patient monitoring solutions across a range of surgical specialties. Senzime’s mission is to develop and make available advanced tools that help hospitals, operating rooms, and other healthcare environments improve the quality of patient care.
Key slides for Senzime
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇸🇪 Sweden